e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
What is new in the approach to pulmonary fibrosis?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The prognostic significance of cardiopulmonary exercise in IPF
C. Triantafillidou, P. Lyberopoulos, L. Kolilekas, K. Kagouridis, S. Gyftopoulos, C. Sotiropoulou, A. Kotanidou, A. Karakatsani, S. Papiris (Athens, Greece)
Source:
Annual Congress 2011 - What is new in the approach to pulmonary fibrosis?
Session:
What is new in the approach to pulmonary fibrosis?
Session type:
Thematic Poster Session
Number:
659
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Triantafillidou, P. Lyberopoulos, L. Kolilekas, K. Kagouridis, S. Gyftopoulos, C. Sotiropoulou, A. Kotanidou, A. Karakatsani, S. Papiris (Athens, Greece). The prognostic significance of cardiopulmonary exercise in IPF. Eur Respir J 2011; 38: Suppl. 55, 659
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
PG16 Advanced cardiopulmonary exercise testing
Measurement properties of field walking tests in chronic respiratory diseases
Related content which might interest you:
The prognostic role of cardiopulmonary exercise testing in disease
Source: International Congress 2019 – PG3 Advanced cardiopulmonary exercise testing
Year: 2019
The prognostic role of cardiopulmonary exercise testing in disease
Source: International Congress 2018 – PG16 Advanced cardiopulmonary exercise testing
Year: 2018
The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis
Source: Annual Congress 2011 - The prognostic value of cardiopulmonary exercise testing
Year: 2011
Cardiopulmonary exercise test as prognostic tool in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2007 - Considerations in the management of idiopathic pulmonary fibrosis and other interstitial lung diseases
Year: 2007
The prognostic value of cardiopulmonary exercise testing in interstitial lung disease: a systematic review
Source: ERJ Open Res, 6 (3) 00027-2020; 10.1183/23120541.00027-2020
Year: 2020
Prognostic predictors for survival in patients with COPD using cardiopulmonary testing
Source: Eur Respir J 2002; 20: Suppl. 38, 285s
Year: 2002
The prognostic value of exercise testing
Source: Breathe 2009; 5: 229-234
Year: 2009
Cardiopulmonary exercise test in COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 88s
Year: 2003
Cardiopulmonary exercise testing in interstitial lung diseases and the value of ventilatory efficiency
Source: Eur Respir Rev, 30 (162) 200355; 10.1183/16000617.0355-2020
Year: 2021
The sPAP/VO2 ratio during cardiopulmonary exercise testing as predictor of manifest pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology
Year: 2012
Value of maximal and submaximal variables during incremental cardiopulmonary exercise testing to predict survival in pateints with pulmonary arterial hypertension (PAH)
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009
The value of cardiopulmonary exercise test in assessment of the severity of pulmonary arterial hypertension patients
Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension
Year: 2017
Any role for cardiopulmonary exercise test in symptomatic smokers with borderline spirometry?
Source: International Congress 2018 – Cardiopulmonary exercise testing in COPD and cardiovascular diseases
Year: 2018
Pulmonary function and cardiopulmonary exercise tests in patients with bronchiectasis
Source: Annual Congress 2010 - Exercise in healthy and non-respiratory diseases
Year: 2010
Exertional dyspnoea in COPD: the clinical utility of cardiopulmonary exercise testing
Source: Eur Respir Rev 2016; 25: 333-347
Year: 2016
Chronotropic incompetence during maximal cardiopulmonary exercise test in patients with COPD and CHF
Source: Annual Congress 2009 - Influence of interventions and comorbidity on exercise performance
Year: 2009
The role of cardiopulmonary exercise test in identifying pulmonary veno-occlusive disease
Source: Eur Respir J, 57 (6) 2100115; 10.1183/13993003.00115-2021
Year: 2021
Cardiopulmonary exercise testing as non-invasive tool for CTEPH treatment effect assessment
Source: Virtual Congress 2021 – Hypoxia, exercise and respiratory function in pathophysiological conditions
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept